Previously, Roberts served as the coordinator of the
He serves as the St. Francis liaison to for the American Heart Association. Within the community, he holds memberships in several local chambers of commerce and serves on the advisory board for the Partnership for a
A native of
To learn more about St. Francis Imaging Services, go to www.stfrancishospitals.org/DesktopDefault.aspx?tabid=85, or http://stfrancisimagingcenter.com.
MOORESVILLE,
They will be learning the latest techniques in knee replacement surgery from physicians with Joint Replacement Surgeons, part of the St. Francis Medical Group.
Four international candidates for the John N. Insall Travelling Fellowship, sponsored by The Knee Society, will visit the hospital Oct. 19-20. They are: Alessandro Bistolfi, M.D.,
“Members of this prestigious group are internationally known for their surgical skills and research, and we are honored they have selected us to share expertise and to learn about the work we perform,” said E. Michael Keating, M.D., orthopedic surgeon with the Center for Hip and Knee Surgery and a Knee Society board member.
Other Knee Society members at the Mooresville center are Drs. John B. Meding, Philip M. Faris, Robert A. Malinzak and Michael E. Berend, an Insall Fellow in 2004.
As part of their training, the Insall physicians will visit 10 internationally recognized joint replacement centers, including the Mooresville hospital.
The Mooresville center has been ranked No. 1 in
To learn more about the Joint Replacement Surgeons, go to http://stfrancishospitals.org/SFMG/DesktopDefault.aspx?tabid=339. More information about the Center for Hip & Knee Surgery is at www.stfrancishospitals.org/Ortho/DesktopDefault.aspx?tabid=23.
He’s Alexander S. Adams, a member of the IMM’s board of directors. He succeeds Carlton Ray, who founded and has guided the race since its inception in 2008.
“Certainly,
Adams, vice president of Fifth Third Bank, was a 22-year member of the Indianapolis Athletic Club. A five-time Boston Marathon runner, he initiated and directed the club’s Shamrock Run/Walk, which over the years expanded to 3,000 entries.
An
The president-elect was named a Sagamore of the
St. Francis Hospital & Health Centers continues in its role as title sponsor of the IMM, which it has done since the IMM’s 2008 inaugural race. Jeff Peterson, M.D., leads a medical team of nearly 100 physicians, nurses, physical therapists and trainers. St. Francis volunteers also help runners and assist in a variety of ways.
The race features a full marathon (26.2 miles) a half marathon (13.1 miles) and an inaugural 5K distance. All courses will begin near
The urban courses are sanctioned and certified by the standards of USA Track and Field, the national body of road racing, with the marathon course serving as a qualifier for the 2011 Boston Marathon.
Several lndianapolis-area educational institutions will get a leg up on their programs. The IMM donates its proceeds to those organizations. Last year’s donations topped $51,000.
To register or to learn more about the IMM go to http://monumentalmarathon.com.
INDIANAPOLIS -- Many who have met or worked with Caroline Fisher, R.N., say they are humbled by the work she does nd the way she cares for patients. But she says it’s she who is honored by her patients’ trust in her.
Fisher will be honored at the third annual Angels of Grace Award luncheon Saturday, Sept. 25. She will receive the Angel Michael Award as a woman who is a defender of the dignity and goodness of others.
Fisher is the coordinator of the St. Francis Center of Hope and a community leader in the care of victims of sexual assault.
A 10-member committee of lay women and Benedictine Sisters at Our Lady of Grace Monastery, Beech Grove, selected her for the third annual Angels of Grace: A Celebration of Women.
“I particularly appreciate the Angel Michael Award, because of the correlation to St. Michael as I know him,” said Fisher. “The ancients gave the care of their sick to St. Michael; thus, he is considered the patron saint of paramedics. This relationship fits well with not only my career as a nurse, but also my love of emergency nursing.
“I go into work to ‘take care’ of patients, and I am the one who is blessed by their strength, honesty and trust,” she said.
Also receiving awards are television journalist Anne Ryder and community activist Julie Molloy.
To register for the Sept. 25 luncheon, call 317-788-7581 or send an e-mail to benedictinn@ benedictinn.org by Sept. 11.
To learn more about the St. Francis Center of Hope go to www.stfrancishospitals.org/DesktopDefault.aspx?tabid=117.
The study involves Lucanix®, which is administered as a vaccine. It’s made from irradiated gene-modified tumor cells. The purpose is to see how well it works compared with a placebo in treating patients with late stage non-small cell lung cancer.
“We want to see if this therapy retrains the patient's immune system to recognize and kill the cancer cells,” said principal investigator Michael Slaughter, M.D., Ph.D, a member of St. Francis Medical Group. “Earlier published test results of Lucanix have shown the survival of patients was double at two years, compared to historic controls – an encouraging outcome not previously seen in advanced lung-cancer patients.”
Slaughter is among a group of top oncologists testing Lucanix, which is manufactured by NovaRx Corp. Similar studies are being conducted throughout the
Slaughter is joined by several St. Francis sub-investigators, including Stephen Eberwine, M.D.; Nadeem Ikhlaque, M.D.; Mary Lou Mayer, M.D.; Stephen Eric Rubenstein, M.D.; Subhash Sharma, M.D.; and Gregory W Smith, M.D.
To be considered for the trial, patients must be between the ages of 18 and 75; have stage IIIA, IIIB, and IV non-small-cell lung cancer; and have completed platinum-based chemotherapy but did not progress on it.
Gene transfer is the process of inserting new laboratory-modified genes into a patient. Many scientists this type of therapy might be an effective way to treat certain health problems.
